Form D · Biotechnology
OCERA THERAPEUTICS INC
San Diego, CA · CIK 0001338321
Offering snapshot reported Apr 5, 2012 · SEC filing
- Reported sold
- $1.5M Offering amount: $3M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 30, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 5, 2012 | Initial | $1,500,150 | No comparison | 15 | SEC filing |
| Feb 13, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 22, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 8, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-176262
Source: Form D, filed Apr 5, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Davie, M.D., Ph.D. | Director |
| Lars Ekman, M.D., Ph.D. | Director |
| Laurent Fischer, M.D. | Director, Executive |
| Linda Grais, M.D. | Director |
| Nina Kjellson | Director |
| Dana Mc Gowan | Executive |
| Michael Powell, Ph.D. | Director |
| Pratik Shah, Ph.D. | Director |
| Eckard Weber, M.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12651 High Bluff Dr Suite 230
San Diego, CA, 92130
San Diego, CA, 92130